New Issue: Orbital Catastrophe Ahead? Read Now

How Do Painkillers Buffer against Social Rejection?

Jeannine Stamatakis, an instructor at various colleges in the San Francisco Bay Area, answers

Join Our Community of Science Lovers!

How do painkillers buffer against social rejection?
Lauren Sippel, State College, Pa.

Jeannine Stamatakis, an instructor at various colleges in the San Francisco Bay Area, answers:

WE OFTEN feel rejected when faced with the popular clique at school or the office bully. Learning to protect yourself against such social assaults can prove quite difficult, but new research shows a common painkiller may reduce the impact of these upsetting interactions.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


A recent study published in the journal Psychological Science suggests that acetaminophen, the active ingredient in Tylenol, may buffer against social pain. The lead investigator, psychologist C. Nathan DeWall of the University of Kentucky, hypothesized that the neural overlap between physical and emotional pain might enable a drug designed to alleviate physical pain to cushion emotional pain.

In one experiment, DeWall and his team examined 62 healthy volunteers who took 1,000 milligrams of either acet­aminophen or a placebo daily for three weeks. In the evening the participants described to what extent they experienced social disappointment or felt upset during the day using a version of the Hurt Feelings Scale, a social pain measurement tool. Participants who took acet­­amin­o­phen reported fewer hurt feelings and more resilience to social pain than the subjects receiving the placebo.

In a second experiment, the investigators looked at 25 healthy volunteers who ingested 2,000 milligrams of either acet­aminophen or a placebo every day over the course of three weeks. During the investigation, subjects played a computer game geared to evoke feelings of social rejection while lying in a functional MRI machine. The resulting brain scans revealed that the participants who received the drug exhibited reduced neural responses to social rejection in brain regions associated with interpreting emotional and physical pain. In contrast, the regions associated with physical pain became more active in the placebo subjects when they were rebuffed in the video game. Overall, these results indicate that acetaminophen may decrease self-reported social pain over time.

Thus, the next time you are taking cold medication, monitor how you feel in social settings and at work. You might be pleasantly surprised by how easily things roll off your back.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe